Platinum Investment Management’s Immunovant IMVT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.52M	Hold	181,774	–	–	1.14%	30
2025 Q4	$4.62M	Sell	181,774 -13,953	-7%	-$311K	1.07%	33
2025 Q3	$3.16M	Hold	195,727	–	–	0.2%	51
2025 Q2	$3.13M	Buy	195,727 +38,738	+25%	+$586K	0.21%	46
2025 Q1	$2.68M	Sell	156,989 -45,334	-22%	-$948K	0.16%	44
2024 Q4	$5.01M	Buy	202,323 +10,081	+5%	+$286K	0.29%	35
2024 Q3	$5.48M	Hold	192,242	–	–	0.25%	37
2024 Q2	$5.08M	Buy	192,242 +1,586	+0.8%	+$45.1K	0.21%	37
2024 Q1	$6.16M	Sell	190,656 -38,109	-17%	-$1.39M	0.25%	37
2023 Q4	$9.64M	Buy	228,765 +2,826	+1%	+$104K	0.39%	40
2023 Q3	$8.67M	Sell	225,939 -102,903	-31%	-$2.33M	0.34%	37
2023 Q2	$6.24M	Sell	328,842 -18,128	-5%	-$338K	0.22%	51
2023 Q1	$5.38M	Sell	346,970 -64,327	-16%	-$1.12M	0.19%	54
2022 Q4	$7.3M	Sell	411,297 -247,778	-38%	-$3.12M	0.28%	44
2022 Q3	$3.68M	Sell	659,075 -118,515	-15%	-$579K	0.15%	55
2022 Q2	$3.03M	Buy	777,590 +90,930	+13%	+$393K	0.11%	66
2022 Q1	$3.78M	Buy	686,660 +70,760	+11%	+$441K	0.12%	63
2021 Q4	$5.25M	Buy	615,900 +60,835	+11%	+$502K	0.15%	61
2021 Q3	$4.82M	Buy	+555,065	New	+$5.01M	0.14%	66